Back to Trials
NCT06288282RecruitingAccepts Healthy Volunteers

Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain

Icahn School of Medicine at Mount Sinai

Start Date

12/20/2023

Completion Date

12/1/2025

Summary

Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * With diagnoses related to chronic lower back pain * Age above 18yrs * Non pregnant Exclusion Criteria: * Cancer pain

Interventions

OTHER

No Intervention

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Chronic Back Pain

Locations

Mount Sinai Pain management centers

New York, New York 10029

United States